Funding Data Link References Status API Help
Page 10 of 307 results
Sort by: relevance publication year

Nilotinib: selective inhibitor as second-line therapy

Journal Article published 13 Oct 2015 in Clinical Management Issues volume 4 issue 6S on page 3

Authors: Massimo Breccia

Successful nilotinib therapy in a CML affected patient with A380T, P407S and V468A mutations, and a previous suboptimal cytogenetic response to imatinib

Journal Article published 13 Oct 2015 in Clinical Management Issues volume 4 issue 6S on page 7

Authors: Fabio Stagno, Alessandra Cupri, Stefania Stella, Michele Massimino, Silvia Rita Vitale, Paolo Vigneri

The role of family caregivers in elderly care in Italy

Journal Article published 15 Dec 2007 in Clinical Management Issues volume 1 issue 4 on page 143

Authors: Giovanni Lamura, Maria Gabriella Melchiorre

Continuity of care as a strategy to face the problems of the twenty-first century

Journal Article published 15 Jun 2009 in Clinical Management Issues volume 3 issue 2 on page 59

Authors: Andrea Pizzini

Off-label prescriptions: taking responsibility

Journal Article published 15 Jun 2011 in Clinical Management Issues volume 5 issue 2 on page 43

Authors: Maria Rosa Luppino

Editorial

Journal Article published 13 Oct 2015 in Clinical Management Issues volume 5 issue 2S on page 3

Authors: Gianlorenzo Imperiale

Hypereosinophilia and hepatitis C

Journal Article published 13 Oct 2015 in Clinical Management Issues volume 5 issue 2S on page 41

Authors: Carlo Bussolino, Valter Saracco

Internal Medicine Investigations in: “The ghost Pheochromocytoma”

Journal Article published 13 Oct 2015 in Clinical Management Issues volume 5 issue 2S on page 81

Authors: Stefano Giordanetti, Giancarlo Vallese, Giovanni Bertinieri

A complicated case of deep vein thrombosis

Journal Article published 15 Mar 2011 in Clinical Management Issues volume 5 issue 1 on page 7

Authors: Elena Cerutti, Paola Colagrande, Edoardo Provera, Massimo Giusti

Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010

Journal Article published 13 Oct 2015 in Clinical Management Issues volume 5 issue 4S on page 13

Authors: Lucia Tozzi